We work with companies across the spectrum of drug discovery and development, from biotechnology start-ups to established pharmaceutical companies.
We provide our services at the engagement level that best suits a client’s specific needs—from undertaking discrete projects to serving as interim C-level executives to help companies operate to their next value inflection.
Mapping strategy to maximize value-creation potential:
We craft strategies and provide thoughtful business planning that serve as a road map for maximizing company value creation.
Business development support to maximize transaction value of your company:
We assist in finding the best partner and help structure and negotiate terms that maximize company transaction value. We support clients throughout the entire transaction process—from sourcing, diligence, and negotiations to transaction close.
Raising capital:
We help clients raise capital—whether a private round of financing or preparation for an IPO and follow-on offerings. We work alongside investment banks and accounting firms to communicate your company’s value proposition.
Our Expertise: Therapeutic Areas & Product Modalities
Our core team has deep experience across a range of therapeutic areas, technologies, and modalities:
Therapeutic Areas:
- Autoimmune / Immunology
- Cardiovascular
- CNS / Neurology
- Infectious Disease
- Endocrine, Renal, & Metabolic
- Gastrointestinal
- Oncology & Immuno-oncology
- Ophthalmology
- Rare Diseases
Product Modalities:
- Antibodies and Bispecifics
- Antibody-Drug Conjugates (ADCs)
- Small Molecules
- Cell Therapy
- Gene Therapy & Gene Editing
- RNA- & DNA-Based Therapeutics
- Vaccines